高质量医院复杂肿瘤手术费用差异研究
研究分析2014至2016年接受胰腺、食管、肺、直肠和结肠癌手术的43007例65至99岁Medicare受益人,聚焦严重并发症率最低五分位的高质量医院。结果显示即便在高质量医院之间,肿瘤手术总费用仍存在显著差异,差异主要来自术后急性期照护和再入院,而非并发症率残余差异。
要点
- 高质量医院间肿瘤手术总费用差异显著,食管切除术差异达16.1%。
- 费用差异最大来源为术后急性期照护支出,其次为再入院。
- 低费用医院术后急性期照护利用率和再入院率均低于高费用医院。
核心结论
- 即使在最高质量的医院中,肿瘤手术费用仍存在显著差异,术后急性期照护差异而非并发症率残余差异解释了大部分费用变异,是提高费用效率的可立即行动目标。
研究设计与样本
- 回顾性队列研究,纳入2014至2016年接受胰腺、食管、肺、直肠和结肠癌手术的65至99岁Medicare受益人,共43007例,高质量医院定义为各手术风险及信度调整后严重并发症率最低五分位。
主要发现
- 高质量医院中总 episode 费用从结肠切除术的18712美元到食管切除术的38054美元不等。
- 最低与最高费用医院间差异从结肠切除术最低三分位的1207美元(95%CI 1195-1220,占总费用6.6%)到食管切除术的5706美元(95%CI 5506-5906,占16.1%)。
- 费用变异最大组成部分为术后急性期照护支出,其次为再入院。
- 食管癌队列中低费用医院风险调整再入院率为17.3%,高费用医院为29.4%(P<.001)。
临床怎么用
- 在高质量医院推进费用效率改进时,应重点优化术后急性期照护路径和再入院管理,而非仅关注并发症率。
局限性
- 研究仅纳入Medicare受益人(65至99岁),结论外推至其他人群需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study evaluates the variation in spending by the highest-quality hospitals performing complex cancer surgery in the United States. SUMMARY BACKGROUND DATA: As mortality rates for high-risk cancer surgery have improved, increased attention has focused on other elements of quality, such as complications. However, high-value surgical care requires both high-quality care and cost savings. Therefore, understanding any residual cost variation among high-quality hospitals is essential to better direct efforts to achieve efficient, high-value care. METHODS: Medicare beneficiaries age 65 to 99 who underwent surgery for pancreas, esophageal, lung, rectal, and colon cancer from 2014 to 2016 were identified. The highest-quality hospitals were identified as those in the quintile with the lowest risk- and reliability-adjusted serious complication rates for each operation. Within this cohort of high-quality hospitals, 30-day total episode, index hospitalization, physician, postacute care, and readmis-sion spending were analyzed. Logistic regression models were utilized to estimate the probability of postoperative outcomes and post-discharge resource utilization. RESULTS: A total of 43,007 Medicare patients underwent either pancreas, esophageal, lung, rectal, or colon resection for cancer at a hospital within the highest-quality quintile. Among the highest quality hospitals, total episode spending ranged from $18,712 for colectomy to $38,054 for esophagectomy. Spending between the lowest- and highest spending hospitals varied from $1207 [confidence intervals (CI 95% ) $1195-$1220] or 6.6% of total episode spending in the lowest tertile for colectomy to $5706 (CI 95% $5,506-$5906) or 16.1% of total episode spending in the lowest tertile for esophagectomy. The largest component of variation was from postacute care spending followed by readmission. For all operations, the risk-adjusted rate of postacute care facility utilization was lower among the lowest spending hospitals compared to the highest spending hospitals. For example, for pancreas the lowest-spending hospitals on average discharged patients to a postacute care facility at a rate of 18,6% (CI 95% 16.2-20.9) compared to 31.0% (CI 95% 28.2-33.9) in the highest-spending hospitals. In all operations, the risk-adjusted readmission rate was lower among the lowest-spending hospitals compared to the highest-spending hospitals. For instance, within the esophagus cohort, the lowest-spending hospitals had an average risk-adjusted readmission rate of 17.3% compared to 29.4% in the highest spending hospitals ( P < .001). CONCLUSIONS AND RELEVANCE: Even among the highest-quality hospitals, significant cost variation persists among cancer operations. Postacute care variation, rather than residual variation in complication rates, explains the majority of this variation and represents an immediately actionable target for increased cost-efficiency.
引用
- Diaz A, Nuliyalu U, Dimick JB, et al. Variation in Surgical Spending Among the Highest Quality Hospitals for Cancer Surgery. Ann Surg. 2020. PMID: 33214485. doi:10.1097/SLA.0000000000004641
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。